Details

Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma
ID Chikhaoui, Asma (Author), ID Režen, Tadeja (Author), ID Komel, Radovan (Author), ID Yacoub-Youssef, Houda (Author), et al.

.pdfPDF - Presentation file, Download (3,20 MB)
MD5: BADE9F89E3A3B764542B40329D2F5B85
URLURL - Source URL, Visit https://www.nature.com/articles/s41598-022-17928-z This link opens in a new window

Abstract
Xeroderma pigmentosum (XP) is a DNA repair disease that predisposes to early skin cancers as cutaneous melanoma. Melanoma microenvironment contains inflammatory mediators, which would be interesting biomarkers for the prognosis or for the identification of novel therapeutic targets. We used a PCR array to evaluate the transcriptional pattern of 84 inflammatory genes in melanoma tumors obtained from XP patients (XP‑Mel) and in sporadic melanoma (SP‑Mel) compared to healthy skin. Commonly expressed inflammatory genes were further explored via GTEx and GEPIA databases. The differentially expressed inflammatory genes in XP were compared to their expression in skin exposed to UVs, and evaluated on the basis of the overall survival outcomes of patients with melanoma. Monocyte subsets of patients with SP‑Mel, XP and healthy donors were also assessed. PCR array data revealed that 34 inflammatory genes were under‑expressed in XP‑Mel compared to SP‑Mel. Differentially expressed genes that were common in XP‑Mel and SP‑Mel were correlated with the transcriptomic datasets from GEPIA and GTEx and highlighted the implication of KLK1 and IL8 in the tumorigenesis. We showed also that in XP‑Mel tumors, there was an overexpression of KLK6 and KLK10 genes, which seems to be associated with a bad survival rate. As for the innate immunity, we observed a decrease of intermediate monocytes in patients with SP‑Mel and in XP. We highlight an alteration in the immune response in XP patients. We identified candidate biomarkers involved in the tumorigenesis, and in the survival of patients with melanoma. Intermediate monocyte’s in patients at risk could be a prognostic biomarker for melanoma outcome.

Language:English
Keywords:xeroderma pigmentosum, cutaneous melanoma, inflammatory mediators, biomarkers, melanoma, monocytes and macrophages, nucleotide excision repair
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2022
Number of pages:13 str.
Numbering:Vol. 12, art. 13854
PID:20.500.12556/RUL-165904 This link opens in a new window
UDC:616-006
ISSN on article:2045-2322
DOI:10.1038/s41598-022-17928-z This link opens in a new window
COBISS.SI-ID:121891075 This link opens in a new window
Publication date in RUL:13.12.2024
Views:377
Downloads:176
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Scientific reports
Shortened title:Sci. rep.
Publisher:Nature Publishing Group
ISSN:2045-2322
COBISS.SI-ID:18727432 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:xeroderma pigmentosum, kožni melanom, vnetni mediatorji

Projects

Funder:Tunisia, Ministry of Public Health

Funder:Tunisia, Ministry of Higher Education and Scientific Research
Project number:LR16IPT05

Funder:IPT
Funding programme:Projet Collaborative Interne
Acronym:PCI_Melanoma

Funder:ARRS - Slovenian Research Agency
Project number:P1-0104
Name:Funkcijska genomika in biotehnologija za zdravje

Funder:ARRS - Slovenian Research Agency
Project number:P1-0390
Name:Funkcijska genomika in biotehnologija za zdravje

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back